Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis

AIM: This study was designed to investigate the relationships of serum matrix metalloproteinase 9 (MMP-9) level and treatment response in esophageal squamous cell carcinoma (ESCC) patients treated with chemotherapy or concurrent radiotherapy. METHODS: Blood samples from ESCC patients after chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Ziqi, Zhao, Hongying, Zhou, Wuyuan, Ye, Tao, Geng, Chong, Li, Xiaofeng, Yuan, Lei, Du, Mingyu, Xu, Heng, Wang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751709/
https://www.ncbi.nlm.nih.gov/pubmed/33364781
http://dx.doi.org/10.2147/OTT.S280791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751709/
https://www.ncbi.nlm.nih.gov/pubmed/33364781
http://dx.doi.org/10.2147/OTT.S280791

Ejemplares similares